Ajanta Pharma Limited
AJANTPHARM
Rank in Stocks
#3707
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Share Price
$36.41
Last synced: 2026-10-19
Market Cap
$4.55B
Change (1 day)
-0.54%
Change (1 year)
31.32%
Country
IN
Trade Ajanta Pharma Limited (AJANTPHARM)
Category
Healthcare
P/B ratio for Ajanta Pharma Limited (AJANTPHARM)
P/B ratio as of October 2026 TTM: 9.22
According to Ajanta Pharma Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 9.22. At the end of 2024 the company had a P/B ratio of 7.90.
P/B ratio history for Ajanta Pharma Limited from 2005 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 9.22 | 6.67% |
| 2025 | 8.64 | 9.39% |
| 2024 | 7.90 | 72.86% |
| 2023 | 4.57 | -4.67% |
| 2022 | 4.79 | -7.95% |
| 2021 | 5.21 | 13.54% |
| 2020 | 4.59 | 13.10% |
| 2019 | 4.06 | -32.88% |
| 2018 | 6.04 | -38.85% |
| 2017 | 9.88 | -6.58% |
| 2016 | 10.58 | -17.66% |
| 2015 | 12.85 | 117.99% |
| 2014 | 5.89 | 51.03% |
| 2013 | 3.90 | 116.82% |
| 2012 | 1.80 | 75.69% |
| 2011 | 1.02 | -10.99% |
| 2010 | 1.15 | 201.10% |
| 2009 | 0.38 | -45.26% |
| 2008 | 0.70 | -3.96% |
| 2007 | 0.73 | -8.05% |
| 2006 | 0.79 | 15.81% |
| 2005 | 0.68 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -45.30% |
IN
|
